Advertisement

Topics

Latest Rheumatology NewsRSS

10:41 EST 20th November 2017 | BioPortfolio

Global Cytotoxic Drug Market Data List by Segment 20152022 [Report Updated: 07112017] Prices from USD $800

SnapshotCytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions e.g., psoriasis, rheumatoid and juvenile rheumatoid arthritis, and steroidresistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplast...

FDA Grants Breakthrough Therapy Designation and Orphan Drug Designation to PellePharm for Topical Patidegib in Gorlin Syndrome

-- PellePharm on track for a Phase 3 clinical trial in 2018 -- PellePharm, a clinical-stage biopharmaceutical company committed to targeting rare genetic dermatological conditions at the source, today announced that the U.S. Food and Drug Administration (FDA) has granted both Breakthrough Therapy Designation and Orphan Drug Designation to topical patid...

Prefilled Drug Cartridge Launched To Treat Arthritis, Other Chronic Conditions

NewsErgonomically designed reusable autoinjector provides an additional administration option for Enbrel (etanercept) users. The new Enbrel Mini with AutoTouch was approved by the FDA in September 2017.

Bay Area's PellePharm Wins FDA Breakthrough Tag for Genetic Rare Disease Drug

The decision was based on results from its Phase 2 trial assessing the safety and efficacy of topical patidegib in patients with Gorlin Syndrome.

Juvenile Idiopathic arthritis JIA Epidemiology Forecast to 2025 [Report Updated: 10102017] Prices from USD $2200

DelveInsight Juvenile Idiopathic arthritis JIA Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Juvenile Idiopathic arthritis JIA in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Juvenile Idiopathic arthritis JIA prevalent or incident cases segmented by age, sex and subpopula...

Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $3500

Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R Pipeline Review, H2 2017SummaryAccording to the recently published report 'Adrenocorticotropic Hormone Receptor Pipeline Review, H2 2017'; Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R pipeline Target constitutes close to 6 ...

Secukinumab demonstrates sustained response, consistent safety profile in AS

SAN DIEGO — Secukinumab provided sustained improvements in signs and symptoms of ankylosing spondylitis among patients who completed three years of treatment, according to data presented at the American College of Rheumatology Annual Meeting.In addition to sustained improvements in physical function at 3 years, secukinumab also demonstrated a safety profile consistent with previous data for this...

Global Artificial Joints Market - Segmentation Analysis and Forecast by Technavio

The latest market research report by Technavio on the global artificial joints market predicts a CAGR of close to 6% during the period 2017-2021. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171117005489/en/

Rheumatology, Managed Care and Burnout

I recently chaired a CME program in Chicago, where I asked a polling question about which “obstacle” was the greatest impediment for effective patient care. Many of the usual suspects were among the responses, such as time crunches, hassles with electronic medical records, patient engagement and adherence issues, and keeping up with the literature, as well as insurance and financial challenges...

Treatment of Giant Cell Arteritis With Tocilizumab: A Historical Perspective

I am thrilled to have Gary S. Hoffman, MD, MS, MACR, write this month’s Guest Editorial for Healio Rheumatology. No one, in my judgment, is better qualified to help us consider how the recent advances in giant cell arteritis will ultimately effect the way we treat the disease and, of course, ultimately how our patients can potentially benefit from these changes. New therapies must be critically ...

Irritable Bowel Syndrome IBS Epidemiology Forecast to 2025 [Report Updated: 10102017] Prices from USD $2200

DelveInsight Irritable Bowel Syndrome IBS Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Irritable Bowel Syndrome IBS in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Irritable Bowel Syndrome IBS prevalent or incident cases segmented by age, sex and subpopulations. The Repo...

U.S. Health Agency To Crack Down On Risky Stem Cell Offerings

NewsMany of the affected businesses promote stem cell injections for dozens of diseases including arthritis, multiple sclerosis, and even Alzheimer's. They can cost $5,000 to $50,000, but there's little research that such procedures are safe or effective.

Juvenile Idiopathic arthritis JIA Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10102017] Prices from USD $4600

DelveInsight's Juvenile Idiopathic arthritis JIA Market Insights, Epidemiology and Market Forecast Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Juvenile Idiopathic arthritis JIA Market Insights, Epidemiology and Market Forecast for the 7MM United States, Germany, France, Italy, Spain and UK for the study peri...

Evolutionary Backtrack Offers Up Novel Rheumatoid Arthritis Candidate

A peptide found exclusively in Old World monkeys has been shown to completely reverse joint disease in a rat model of rheumatoid arthritis (RA), and could represent a new form of "retroevolutionary’" therapy for RA in humans, according to researchers in the U.S. The peptide, known as rhesus θ-defensin 1 (RTD-1), is the prototype of a family of small cyclic θ-defensins, which are the ...

Loss of efficacy after switching to biosimilar infliximab in Behcet’s patients

Authors from the Division of Rheumatology at the Hospital of Prato, Italy report on three patients with Behçet’s disease that experienced disease relapses after switching from the originator infliximab, Remicade, to biosimilar infliximab [1].

Prescribe exercise like you prescribe medicine

We have all seen and heard the story: a patient who is overweight and has heart problems (or arthritis, diabetes, low back pain or any number of other chronic conditions) is told by their doctor that they need to exercise. The patient agrees, “Yes, I really will try to start an exercise program.” Six months […]

Lennox Gastaut Syndrome Epidemiology Forecast to 2025 [Report Updated: 10102017] Prices from USD $2200

DelveInsight Lennox Gastaut Syndrome Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Lennox Gastaut Syndrome in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Lennox Gastaut Syndrome prevalent or incident cases segmented by age, sex and subpopulations. The Report also discuss...

Fear of movement reduces quality of life for people with osteoarthritis

People with knee osteoarthritis are experiencing a decreased quality of life due to a fear of movement associated with the condition, says research published in Arthritis Care & Research. And this fear of movement may be causing those with osteoarthritis to lead less active lifestyles, putting them at risk of their condition becoming worse. A […] The post Fear of movement reduces quality...

PeerWell Launches PreHab Program for Same-Day Surgery Patient

PeerWell, a healthcare technology company helping patients prepare and recover from orthopedic surgery, announced an extension to their platform for outpatient joint replacement centers. Previously the platform had only been available to inpatients.    Experts estimate that the demand for orthopedic surgeries will grow by 77 percent over the next 10 years with a predicted 50 percent or more ...

GuillainBarre Syndrome GBS Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10102017] Prices from USD $4600

DelveInsight's GuillainBarre Syndrome GBS Market Insights, Epidemiology and Market Forecast Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to GuillainBarre Syndrome GBS Market Insights, Epidemiology and Market Forecast for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken ...

Monoclonal antibody shown to be safe, effective in managing PsA

SAN DIEGO – Treatment with ABBV-066, a monoclonal antibody that inhibits interleukin-23, provided substantial improvements in joint and skin scores among patients with psoriatic arthritis, according to findings presented at the American College of Rheumatology Annual Meeting.In addition, no novel or surprising side effects were observed with ABBV-066 (risankizumab, AbbVie) in this double-blind, ...

Vium Announces First Peer-Reviewed Publication for its Digital Vivarium® Technology

Publishes successful results of the Digital Arthritis Index to benefit Rheumatoid Arthritis Research Vium, a preclinical drug discovery platform company, announced today the publication of a peer reviewed paper in the journal Frontiers in Pharmacology. The article titled “Development of the Digital Arthritis Index, a Novel Metric to M...

Zen Relief Balm Battles the American Opioid Epidemic

The All Natural Pain Relief is the Safe, Effective, and Quick Acting Solution for the Opioid Addiction Epidemic Las Vegas Nevada (PRWEB) November 16, 2017 Zen Relief Balm, headquartered in Las Vegas, Nevada has launched in Rite Aid retailers across the United States just in time to battle the Opioid Epidemic. The Centers for Disease Control and Prevention finds that 91 Americans die every day fro...

Estée Lauder, Google Home join forces to create personalized nighttime routine

Gisselle GaitanThe joint venture will officially launch in Dec., with new activations and a global rollout in early 2018.  read more

CAM use leads to delays in appropriate, effective arthritis therapy

A preference to use CAM before seeking medical advice may be harming patients with inflammatory arthritis.

Quick Search
Advertisement
 

review and buy Rheumatology market research data and corporate reports here